The Morningstar Wide Moat Focus Index retreated along with the broad U.S. equity market in December, falling 4.5% during the ...

Northern Technologies International's Q1 results showed bioplastics growing, industrial segments flat. Click here to read why ...

Oil prices have started 2025 strong, defying expectations of a downturn fueled by worries about slowing demand. Click to read ...

The iShares MSCI Turkey ETF shows cheap valuations but weak GDP prospects. Read why TUR's technicals and macro factors make ...

Ryder System's shares have surged significantly, outperforming the S&P 500, and remain attractively priced, justifying a ...

It is unsurprising that Affirm has raised its FY2025 guidance. Click here to read why we believe that AFRM stock deserves a ...

Dexterra's Q3 2024 results show revenue increase, dividend declaration, stock buyback, and potential for acquisitions. Click ...

Novo Nordisk (NVO) and Eli Lilly's (LLY) weight loss drugs lead Evaluate Pharma’s list of best-selling drugs projected for ...

IGM Biosciences (IGMS) is slashing its workforce by 73% and discontinuing development of two of its lead drug candidates in ...

Rising data center power demands, driven by AI adoption, highlight the increasing importance of nuclear energy for efficient ...

ARKF ETF has sold $15 million worth of shares of Palantir stock, may have caused a bit of a sell-off. See why I maintain a ...

Enterprise Products Partners shows strong business fundamentals, but its valuation is undervalued. Click here to find out why ...